NasdaqGS:HSICHealthcare
How Investors Are Reacting To Henry Schein (HSIC) Earnings Miss On Softer U.S. Dental Product Demand
Earlier this week, Henry Schein reported that although its Q2 2025 revenue surpassed expectations, adjusted earnings per share missed forecasts due to reduced demand for U.S. dental products amid high interest rates and inflation.
This performance comes as the company continues its investor outreach at major healthcare conferences and highlights sustained commitment to corporate citizenship initiatives through programs supporting students globally.
We'll now explore how the recent earnings...